US-based biotechnology firm Thermo Fisher Scientific has unveiled a new capillary electrophoresis (CE) system called Applied Biosystems SeqStudio Genetic Analyser.

Intended for Sanger sequencing and fragment analysis, the low-throughput, cartridge-based system has applications in a variety of divisions, including oncology research, species identification, genome editing and human cell line authentication.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The new device features a cartridge with a combination of capillary array, polymer reservoir and anode buffer to allow easy preparation and quick processing.

The analyser also includes access to individualised protocols, intuitive touchscreen and connectivity to the firm’s cloud to enable remote setup and monitoring, easy collaboration and data analysis.

"The new device features a cartridge with a combination of capillary array, polymer reservoir and anode buffer to allow easy preparation and quick processing."

Thermo Fisher Scientific Genetic Analysis vice-president and general manager Kim Kelderman said: "Sanger sequencing using CE, which is celebrating its 40th anniversary this year, is the gold standard sequencing technology.

“It helped discover novel biological findings such as the first breast cancer gene (BRCA1) and was used to complete the Human Genome Project in 2003."

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The device facilitates operation of both sequencing and fragment analysis on the same CE plate, resulting in new analyses opportunities such as a combination of a locus screening test and a copy number variability test on the same plate.

Currently in use by certain North American, EMEA, Japanese and Chinese customers, the Applied Biosystems SeqStudio Genetic Analyser will be available in other international markets from the second half of this year.

Image: The new SeqStudio Genetic Analyser. Photo: courtesy of PRNewsfoto/Thermo Fisher Scientific Inc.